US Stock MarketDetailed Quotes

VYGR Voyager Therapeutics

Watchlist
  • 8.370
  • -0.060-0.71%
Close Jul 19 16:00 ET
455.27MMarket Cap-49235P/E (TTM)

About Voyager Therapeutics Company

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.

Company Profile

SymbolVYGR
Company NameVoyager Therapeutics
Listing DateNov 11, 2015
Issue Price14.00
Founded2013
CEODr. Alfred W. Sandrock, Jr,M.D.,PhD
MarketNASDAQ
Employees162
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address75 Hayden Avenue
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-857-259-5340
Websitehttp://www.voyagertherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Alfred W. Sandrock, Jr,M.D.,PhD
  • Director, President and Chief Executive Officer
  • 3.17M
  • Toby Ferguson
  • Chief Medical Officer
  • --
  • Jacquelyn Fahey Sandell, J.D.
  • Chief Legal Officer
  • 1.68M
  • Robin Swartz
  • Chief Operating Officer
  • 1.38M
  • Dr. Nathan Jorgensen, M.B.A.,PhD
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Todd Carter, PhD
  • Chief Scientific Officer
  • --
  • Michael J. Higgins
  • Chairman of the Board
  • 281.28K
  • Dr. Jude Onyia, PhD
  • Director
  • 452.32K
  • Dr. Catherine J. Mackey, PhD
  • Independent Director
  • 250.78K
  • Dr. Grace E. Colon, PhD
  • Independent Director
  • 432.23K
  • Dr. Steven E. Hyman, M.D.
  • Independent Director
  • 255.78K
  • Dr. George A. Scangos,PhD
  • Independent Director
  • 559.79K
  • Nancy Vitale
  • Independent Director
  • 255.28K
  • James A. Geraghty
  • Independent Director
  • 263.78K
  • Dr. Glenn F. Pierce, M.D.,PhD
  • Independent Director
  • 248.78K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg